ITL Health Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ITL Health Group - overview
Established
1994
Location
Canberra, ACT, Australia
Primary Industry
Medical Devices & Equipment
About
ITL Health Group is dedicated to providing innovative solutions for blood management and clinical procedures, focusing on enhancing patient outcomes across healthcare sectors. Founded in 1994 and headquartered in Canberra, Australia, ITL Health Group specializes in blood management solutions. The company has undergone strategic developments to align its offerings with evolving healthcare needs. Bill Mobbs, one of the founders, has played a significant role in shaping the company's vision, which is supported by a diverse leadership team including Craig Wilson, Pete Evans, Tony Zhang, Viacheslav Ermilov, and Viktor Lus.
ITL Health Group has successfully completed a total of 2 deals and exited its stake in its subsidiary. ITL Health Group specializes in innovative tools for blood management and clinical procedures, primarily through its subsidiary, ITL BioMedical. The company provides advanced solutions designed to improve efficiency and safety during clinical procedures. Its diverse client base includes hospitals, blood banks, and clinical laboratories across North America, Europe, Asia-Pacific, and the Middle East.
The company has a substantial portfolio of intellectual property that supports the functionality and reliability of its product range. In 2010, ITL Health Group reported a revenue of USD 36. 07 mn and an EBITDA of USD 970,200. Revenue is primarily generated through direct sales to healthcare institutions and bulk supply agreements with medical distributors, ensuring stable streams through long-term contracts.
ITL Health Group aims to expand its market presence by introducing new products and entering new geographic regions. Specific plans include targeting expansion in regions of Asia-Pacific and Europe by 2024. The company intends to utilize recent funding to support these initiatives, further enhancing its product offerings and operational capabilities.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Supplies, Medical Equipment Distributors
Website
www.itlhealthgroup.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
ITL Health Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PIPE | Completed | ITL Health Group | - | ||||||||
| Private Placement/Follow on | Completed | ITL Health Group | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.